Technical Analysis for FLGT - Fulgent Genetics, Inc.

Grade Last Price % Change Price Change
grade B 36.14 21.72% 6.45
FLGT closed up 21.72 percent on Wednesday, August 5, 2020, on 3.44 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical FLGT trend table...

Date Alert Name Type % Chg
Gilligan's Island Sell Setup Bearish Swing Setup 0.00%
New 52 Week Closing High Bullish 0.00%
Expansion Breakout Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
New 52 Week High Strength 0.00%
Parabolic Rise Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Earnings Movers Other 0.00%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Fulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. As of December 31, 2015, the Company's test menu includes approximately 18,000 single-gene tests and over 200 pre-established, multi-gene, disease-specific panels that collectively test for approximately 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders. The Company's gene probes are specifically engineered to generate genetic data that is optimized for its software, which enables to rapidly incorporate new genes into its test menu, develop new panels of disease-specific tests and customize tests for its customers.
Medicine Biotechnology Technology Cancers Genetics Medical Tests Medical Genetics Neurological Disorders Cardiovascular Diseases Molecular Diagnostics Applied Genetics Genetic Testing Qiagen Alternatives To Animal Testing

Is FLGT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 43.64
52 Week Low 6.7
Average Volume 518,913
200-Day Moving Average 14.90
50-Day Moving Average 19.29
20-Day Moving Average 23.02
10-Day Moving Average 26.46
Average True Range 2.83
ADX 49.49
+DI 60.13
-DI 3.75
Chandelier Exit (Long, 3 ATRs ) 35.14
Chandelier Exit (Short, 3 ATRs ) 26.14
Upper Bollinger Band 32.31
Lower Bollinger Band 13.73
Percent B (%b) 1.21
BandWidth 80.72
MACD Line 3.45
MACD Signal Line 2.25
MACD Histogram 1.2025
Fundamentals Value
Market Cap 641.15 Million
Num Shares 17.7 Million
EPS -0.75
Price-to-Earnings (P/E) Ratio -48.19
Price-to-Sales 3.32
Price-to-Book 1.24
PEG Ratio 0.85
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 50.06
Resistance 3 (R3) 51.01 47.33 47.74
Resistance 2 (R2) 47.33 43.78 46.85 46.97
Resistance 1 (R1) 41.73 41.59 39.89 40.78 46.19
Pivot Point 38.05 38.05 37.13 37.57 38.05
Support 1 (S1) 32.45 34.50 30.61 31.50 26.09
Support 2 (S2) 28.77 32.31 28.29 25.31
Support 3 (S3) 23.17 28.77 24.54
Support 4 (S4) 22.22